April 17, 2019Open Access

Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma

Key Points

Key points are not available for this paper at this time.

Abstract

: CGGA: Chinese Glioma Genome Atlas; TCGA: The Cancer Genome Atlas; TAMs: Tumor associated macrophages; IDH: isocitrate dehydrogenase; GBM: glioblastoma.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper

Cite This Study

Liu et al. (Wed,) studied this question.

synapsesocial.com/papers/6a0f886692676d5461fccb10 https://doi.org/https://doi.org/10.1080/2162402x.2019.1601478

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Central Nervous System Tumors2007 · 340 citations
2The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary2016 · 15,966 citations
3High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma2014 · 109 citations
4Immunotherapy of malignant brain tumors2008 · 101 citations
5A Monoclonal Antibody to a Novel Differentiation Antigen on Human Macrophages Associated with the Down-Regulatory Phase of the Inflammatory Process2008 · 242 citations